A 21 year old male developed hallucinations, personality change and severe depression following an increase in oral propranolol administration at recommended dosage levels. The symptoms improved markedly on stopping the drug. Without provocation, the patient developed further symptoms, mainly depressive, with marked suicidal impulses. Again, this quickly settled. The case identifies the need for careful observation of patients with psychiatric side effects from propranolol, following discontinuation of the drug.
Introduction
Propranolol is extensively used for a wide variety of conditions. Psychiatric side effects including visual hallucinations,1 2 auditory hallucinations,3 depression4'5 and paranoid psychosis3 have been reported, but all have responded to withdrawal of the drug. The present report concerns a profound depression occurring shortly after the drug was discontinued in a patient presenting with a propranolol-induced psychosis. This serious reaction has not been described before.
Case report A 21 year old man with a 10-year history of migraine was treated with oral propanolol 80 mg twice daily for 9 months. This gave inadequate prophylaxis and the dose was therefore increased to 80 mg three times daily. No further attacks occurred. After 6 weeks at the higher dose he began to experience visual hallucinations involving spiders, auditory hallucinations in which a voice whispered his name, vivid, recurrent nightmares, depressed mood with suicidal impulses, and personality change with odd behaviour and violent outbursts. One of these outbursts occurred at work when he pushed a colleague from the cab of an excavator in a quarry, with potentially tragic consequences. On another occasion he noticed that he was being 'flashed' by other drivers on a motorway, only to find that, to his surprise, he had been driving along at 20 miles per hour without realizing it. He had no previous psychiatric history and an even-tempered, outgoing premorbid personality.
On Propranolol is a P-adrenergic receptor antagonist which is strongly lipophilic and known to be centrally active in man. Although psychiatric side effects have been reported for nearly 20 years, and are recognized by the manufacturers in the USA, they do not appear on the UK data sheet. Propranolol is very widely prescribed and it is important that clinicians be aware of the full range of psychiatric morbidity associated with this drug.
